Menstrual Irregularity
Menstrual Irregularity is a hormonal condition involving periods that do not follow a regular pattern. It may be discussed in relation to Vitex Agnus-Castus, which is listed as a potential supportive option in the grounding data.
Menstrual irregularity refers to changes in the usual timing or pattern of periods. This page gives a simple overview of the condition in a hormonal health context.
This list shows research findings, not treatments. Nothing here replaces medical care. If you have this condition, talk to a doctor.
What may help
None of these options has good evidence yet. Best evidence first.
1 option:1 not enough evidence
YogapracticeNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit.
One trial found that Yoga Nidra plus medications reduced pain symptoms compared with medications alone.
Open the Yoga page
The expert view shows every study, dose protocol and source.
What may help
Interventions recorded as helping with this condition1 listedThe best we have, but the evidence is still weak
- →PracticesYogaCertaintyLowSourceRCT
One trial found that Yoga Nidra plus medications reduced pain symptoms compared with medications alone (n = 150).
Who was studied
- People with a condition
- Back Pain
- Depression
- Dysmenorrhea
- Menstrual Irregularity
- Pregnancy
- Surgery Post
Open YogaStudy result
One RCT (n = 150) found YGN plus medications significantly reduced pain symptoms versus medications alone.
What to avoid
Interventions recorded as making it worseNothing in this library is currently recorded as making Menstrual Irregularity worse. Coverage is partial, and absence here is not evidence of safety.
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Menstrual Irregularity is a hormonal condition involving periods that do not follow a regular pattern. It may be discussed in relation to Vitex Agnus-Castus, which is listed as a potential supportive option in the grounding data.
Because menstrual changes can have different causes, the most useful approach is to look at the overall pattern and consider the context with a clinician. This page provides educational information rather than medical advice.
Evidence-backed options
One evidence-backed option listed for Menstrual Irregularity is Vitex Agnus-Castus. The available support is very limited, so this should be read as a possible option rather than a well-established treatment.
Because the evidence is classified as very low and comes from a pharmacology reference, it suggests only that there is some grounding for a benefit, not that the effect is confirmed or broadly proven. For a condition like menstrual irregularity, that means the option may be worth noting in a clinical discussion, but the current evidence base is not strong enough to make firm conclusions.
If menstrual irregularity is being evaluated, it is reasonable to consider evidence quality when comparing options. A clinician can help interpret whether a low-evidence option like Vitex Agnus-Castus fits the broader situation and whether other causes or treatments should be considered.